文献速递胰腺与胆道疾病

钙离子内流通道抑制因子SARAF可保护小鼠免受急性胰腺炎

Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis.
PubMed 文献 · Gastroenterology · 2019-09-04

该研究探讨了腺泡细胞钙离子通道及其调节因子SARAF在急性胰腺炎中的作用。通过CRISPR/Cas9基因编辑小鼠及患者胰腺组织分析,发现SARAF在刺激后先升高后降解,导致病理性钙内流;敲除SARAF加重胰腺炎,而过表达SARAF则减轻炎症和严重程度。提示稳定或恢复SARAF可能成为治疗胰腺炎的策略。

要点

  • SARAF在急性胰腺炎中先升高后降解,导致腺泡细胞钙内流过度。
  • 敲除SARAF的小鼠胰腺炎更严重,过表达SARAF则减轻胰腺炎。
  • 胰腺炎患者胰腺组织中SARAF mRNA水平降低。

核心结论

  • SARAF在急性胰腺炎中先增加后降解,导致腺泡细胞病理性钙内流过度;SARAF缺失加重胰腺炎,而过表达SARAF减轻胰腺炎,提示稳定或恢复SARAF可能治疗胰腺炎。

研究设计与样本

  • 使用CRISPR/Cas9基因编辑构建表达HA标签SARAF的小鼠,并采用Saraf-/-、Sarafzf/zf、对照及腺泡细胞过表达荧光标记SARAF的小鼠。
  • 在HEK细胞和小鼠腺泡细胞中研究STIM1与SARAF的相互作用,并使用卡巴胆碱刺激。
  • 通过注射雨蛙素或L-精氨酸诱导小鼠胰腺炎,收集胰腺组织和血样,检测血清淀粉酶、胰蛋白酶、组织损伤、炎症介质和炎症细胞。
  • 对6名无胰腺疾病的器官捐献者(对照)和8名酒精相关性胰腺炎患者的胰腺组织进行定量PCR分析。

主要发现

  • 胰腺炎小鼠与对照小鼠的腺泡细胞中钙内流通道或STIM1的胰腺水平无显著差异。
  • 在细胞刺激或用雨蛙素注射小鼠期间,SARAF mRNA和蛋白水平 initially 显著增加,但随后降低,导致钙内流过度。
  • 生理浓度卡巴胆碱刺激后STIM1与SARAF稳定结合,而病理浓度卡巴胆碱刺激后仅短暂结合,导致钙内流过度。
  • 胰腺炎患者胰腺组织中SARAF mRNA水平较对照降低。
  • Saraf敲除小鼠在给予雨蛙素或L-精氨酸后胰腺炎比对照小鼠更严重,腺泡细胞钙内流显著增加;相反,腺泡细胞过表达SARAF减少钙内流、消除炎症并降低急性胰腺炎严重程度。

临床怎么用

  • SARAF可能是急性胰腺炎治疗的潜在靶点,策略包括稳定或恢复腺泡细胞中的SARAF。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Pancreatitis is characterized by increased influx of Ca2+ into acinar cells, by unknown mechanisms. Inhibitors of Ca2+ influx channels could be effective in treating acute pancreatitis, but these have deleterious side effects that can result in death. We investigated the expression patterns and functions of acinar cell Ca2+ channels and factors that regulate them during development of acute pancreatitis, along with changes in the channel inactivator store-operated calcium entry-associated regulatory factor (SARAF). We investigated whether SARAF is a target for treatment of acute pancreatitis and its status in human with pancreatitis. METHODS: We generated mice that expressed SARAF tagged with hemagglutinin, using CRISPR/Cas9 gene editing, and isolated acinar cells. We also performed studies with Saraf-/- mice, Sarafzf/zf mice, mice without disruption of Saraf (control mice), and mice that overexpress fluorescently labeled SARAF in acinar cells. We analyzed interactions between stromal interaction molecule 1 (STIM1) and SARAF in HEK cells stimulated with carbachol using fluorescence resonance energy transfer microscopy and immunoprecipitation. Mice were given injections of caerulein or L-arginine to induce pancreatitis. Pancreatic tissues and blood samples were collected and levels of serum amylase, trypsin, tissue damage, inflammatory mediators, and inflammatory cells were measured. We performed quantitative polymerase chain reaction analyses of pancreatic tissues from 6 organ donors without pancreatic disease (controls) and 8 patients with alcohol-associated pancreatitis. RESULTS: Pancreatic levels of Ca2+ influx channels or STIM1 did not differ significantly between acinar cells from mice with vs. without pancreatitis. By contrast, pancreatic levels of Saraf messenger RNA and SARAF protein initially markedly increased but then decreased during cell stimulation or injection of mice with caerulein, resulting in excessive Ca2+ influx. STIM1 interacted stably with SARAF following stimulation of HEK or mouse acinar cells with physiologic levels of carbachol, but only transiently following stimulation with pathologic levels of carbachol, leading to excessive Ca2+ influx. We observed reduced levels of SARAF messenger RNA in pancreatic tissues from patients with pancreatitis, compared with controls. SARAF knockout mice developed more severe pancreatitis than control mice after administration of caerulein or L-arginine, and pancreatic acinar cells from these mice had significant increases in Ca2+ influx. Conversely, overexpression of SARAF in acini reduced Ca2+ influx, eliminated inflammation, and reduced severity of acute pancreatitis. CONCLUSIONS: In mice with pancreatitis, SARAF initially increases but is then degraded, resulting in excessive, pathological Ca2+ influx by acinar cells. SARAF knockout mice develop more severe pancreatitis than control mice, whereas mice that express SARAF from a transgene in acinar cells develop less-severe pancreatitis. SARAF therefore appears to prevent pancreatic damage during development of acute pancreatitis. Strategies to stabilize or restore SARAF to acinar cells might be developed for treatment of pancreatitis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Son A, Ahuja M, Schwartz DM, et al. Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis. Gastroenterology. 2019. PMID: 31493399. doi:10.1053/j.gastro.2019.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。